Sun Pharmaceutical Industries informs about press release

10 Feb 2023 Evaluate
Sun Pharmaceutical Industries has informed that it enclosed Press Release relating to US FDA approval for generic Lenalidomide capsules.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1794.30 -12.60 (-0.70%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×